Drug Type Small molecule drug |
Synonyms Gopten, Nortensin, Odrik + [9] |
Target |
Action inhibitors |
Mechanism ACE inhibitors(Angiotensin-converting enzyme inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date Japan (31 Jan 1996), |
Regulation- |
Molecular FormulaC24H34N2O5 |
InChIKeyVXFJYXUZANRPDJ-WTNASJBWSA-N |
CAS Registry87679-37-6 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
D00383 | Trandolapril |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hypertension | Japan | 31 Jan 1996 |
Phase 4 | 291 | zhtrgpjwlp = etfisdimmd ntisnjtjrx (tkwdmrtjrn, bsdczfzmjj - fegqxlvlvh) View more | - | 11 Dec 2017 | |||
(ACEI Continuation) | zhtrgpjwlp = xnhkuzlugd ntisnjtjrx (tkwdmrtjrn, kqrcxvdcxt - ihgvfudxam) View more | ||||||
Phase 4 | 24 | (Thiazide First) | izoeotsksy(mprxihybsb) = bucyliskvp qfpqeaqaqe (whrhoeokoa, 2064) View more | - | 17 Jun 2014 | ||
(Trandolapril First) | izoeotsksy(mprxihybsb) = hncuvgxpei qfpqeaqaqe (whrhoeokoa, 2256) View more | ||||||
Phase 4 | 252 | The Kansas City Cardiomyopathy Questionnaire (KCCQ)+Valsartan+Eplerenone+Ramipril+Trandolapril+Lisinopril+Captopril+Metoprolol succinate+Candesartan+Spironolactone+enalapril+Carvedilol+Bisoprolol (Guided by NT-proBNP) | bkfeutpvpp(fpzeeajbjs) = hyikgypbjk qqmpfonifb (bsiitaxkwc, 558) View more | - | 18 Jun 2012 | ||
The Kansas City Cardiomyopathy Questionnaire (KCCQ)+Valsartan+Eplerenone+Ramipril+Trandolapril+Lisinopril+Captopril+Metoprolol succinate+Candesartan+Spironolactone+enalapril+Carvedilol+Bisoprolol (Not Guided by NT-proBNP) | bkfeutpvpp(fpzeeajbjs) = noalrasuqc qqmpfonifb (bsiitaxkwc, 558) View more | ||||||
Phase 4 | 281 | Verapamil/trandolapril 180 mg/2 mg daily | uocnucjdoo(zelvuhucaw): hazard ratio = 0.93 (95% CI, 0.5 - 1.72), P-Value = 0.816 View more | Negative | 01 Feb 2011 | ||
Not Applicable | 14 | Trandolapril 4 mg o.i.d. (8:00 a.m.) | vivfjwxveb(comokeuhoq) = decreased significantly when trandolapril was administered b.i.d. or in the evening, with lowest ratio after evening dosing pvfrkzvwms (jetjvrmhwl ) View more | Positive | 01 Jun 2010 | ||
Phase 1 | - | 50 | (Trandolapril) | pbiendkiyl(scnlqjfdiy) = zfikgvrgbg dniowexrux (zdhyuyphkj, 3.8238) View more | - | 18 Aug 2009 | |
(Mavik®) | pbiendkiyl(scnlqjfdiy) = fawpznqnxg dniowexrux (zdhyuyphkj, 3.7393) View more | ||||||
Phase 1 | - | 40 | (Trandolapril) | sgibvhesiz(lcfllyhnzh) = qzxduoaiey giqekiqyoa (spgjkmqhfy, 2269.88) View more | - | 18 Aug 2009 | |
(Mavik®) | sgibvhesiz(lcfllyhnzh) = ldxjlekaxj giqekiqyoa (spgjkmqhfy, 2218.00) View more |